Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05210777 · ClinicalTrials.gov registry record
Norms and Validation for IntelliSpace Cognition Spanish Version
A clinical trial, sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization.
- Completed
- Registry status
- 99
- Enrollment target
NCT05210777: Completed study, sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization.
NCT05210777 is a clinical trial that has completed, run by Philips Electronics Nederland B.V. acting through Philips CTO organization. The registered enrollment target is 99 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05210777 has completed, sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
This study aims to validate and provide applicable norms for the United States (US) Spanish versions of the IntelliSpace Cognition (ISC) neuropsychological tests.
Primary Outcome
To collect test scores from Spanish speaking Hispanic US population for Spanish translations/adaptations of the ISC tests with the aim to assess how the Spanish language version of ISC tests compare to the English language version of ISC tests, and to create norms for the Spanish language version of the tests.
Interventions
- DEVICE observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2022-01-31 |
| Est. Completion | 2022-05-19 |
What the finished NCT05210777 record still lists
NCT05210777 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 99 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which observation is the first listed.
NCT05210777 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05210777 about?
NCT05210777 is a clinical study titled "Norms and Validation for IntelliSpace Cognition Spanish Version". This study aims to validate and provide applicable norms for the United States (US) Spanish versions of the IntelliSpace Cognition (ISC) neuropsychological tests.
What is the current status of trial NCT05210777?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2022-01-31. Estimated completion is 2022-05-19.
What interventions are being tested in trial NCT05210777?
The interventions under investigation include: observation (DEVICE).
Who is sponsoring clinical trial NCT05210777?
This trial is sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI